Your Health, We Care
On September 4, 2020, the U.S. Food and Drug Administration (FDA) approved Pralsetinib (trade name: Gavreto) for the treatment of adult patients with metastatic RET gene fusion-positive non-small cell lung cancer.
On December 1, 2020, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Pralsetinib (trade name: Gavreto) for the treatment of patients with advanced or metastatic RET gene mutation-positive and RET gene fusion-positive thyroid cancer.
On August 9, 2023, the U.S. Food and Drug Administration (FDA) approved Pralsetinib (trade name: Gavreto) for the routine treatment of RET gene fusion-positive non-small cell lung cancer.
On December 1, 2020, South San Francisco, California – Genentech, a member of the Roche Group, annou···【more】
Recommended：622026-15-01
On August 9, 2023, the U.S. Food and Drug Administration (FDA) approved pralsetinib (trade name: Gav···【more】
Recommended：492026-15-01
On December 1, 2020, South San Francisco, California – Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto™ (pra···【more】
Article source：Lucius LaosRelease date：2026-01-15Recommended：62
On August 9, 2023, the U.S. Food and Drug Administration (FDA) approved pralsetinib (trade name: Gavreto, developed by Genentech) for regular use in adult patients with metastatic ···【more】
Article source：Lucius LaosRelease date：2026-01-15Recommended：49
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
